Korean Drug (Korea) Technical Analysis
| 014570 Stock | KRW 4,470 10.00 0.22% |
As of the 25th of November, Korean Drug secures the Risk Adjusted Performance of (0.11), standard deviation of 1.58, and Mean Deviation of 1.08. Korean Drug Co technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Korean Drug Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Korean, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to KoreanKorean |
Korean Drug technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Korean Drug Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Korean Drug volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Korean Drug Trend Analysis
Use this graph to draw trend lines for Korean Drug Co. You can use it to identify possible trend reversals for Korean Drug as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Korean Drug price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Korean Drug Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Korean Drug Co applied against its price change over selected period. The best fit line has a slop of 11.08 , which may suggest that Korean Drug Co market price will keep on failing further. It has 122 observation points and a regression sum of squares at 4647112.45, which is the sum of squared deviations for the predicted Korean Drug price change compared to its average price change.About Korean Drug Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Korean Drug Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Korean Drug Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Korean Drug price pattern first instead of the macroeconomic environment surrounding Korean Drug. By analyzing Korean Drug's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Korean Drug's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Korean Drug specific price patterns or momentum indicators. Please read more on our technical analysis page.
Korean Drug November 25, 2024 Technical Indicators
Most technical analysis of Korean help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Korean from various momentum indicators to cycle indicators. When you analyze Korean charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (22.95) | |||
| Mean Deviation | 1.08 | |||
| Coefficient Of Variation | (682.58) | |||
| Standard Deviation | 1.58 | |||
| Variance | 2.49 | |||
| Information Ratio | (0.23) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (22.96) | |||
| Maximum Drawdown | 10.37 | |||
| Value At Risk | (3.02) | |||
| Potential Upside | 1.78 | |||
| Skewness | (0.23) | |||
| Kurtosis | 3.26 |
Complementary Tools for Korean Stock analysis
When running Korean Drug's price analysis, check to measure Korean Drug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Korean Drug is operating at the current time. Most of Korean Drug's value examination focuses on studying past and present price action to predict the probability of Korean Drug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Korean Drug's price. Additionally, you may evaluate how the addition of Korean Drug to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |